Search
Search Results
-
Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study
BackgroundSeveral studies have highlighted the possible positive effects of soluble receptor for advanced glycation end products (sRAGE) against...
-
The Decrease in Serum sRAGE Levels Upon Smoking is Associated with Activated Neutrophils
The serum level of the soluble Receptor for Advanced Glycation End-products (sRAGE) is a promising blood biomarker for the development, severity, and...
-
Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma
PurposeThe receptor for advanced glycation end products (RAGE) upregulated during the onset and progression of cancer and bone-related pathologies....
-
Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans
BackgroundThere is a strong need for biomarkers to better characterize individuals with COPD and to take into account the heterogeneity of COPD. The...
-
Association between plasma sRAGE and emphysema according to the genotypes of AGER gene
BackgroundHigher soluble receptor for advanced glycation end product (sRAGE) levels are considered to be associated with severe emphysema. However,...
-
Effect of irisin on metabolic and platelet functions in type 2 diabetic rats: role of soluble receptor of advanced glycation end products (sRAGE)
BackgroundIrisin is an adipomyokine with a promising potential for the treatment of metabolic disturbances and endothelial dysfunction. This study...
-
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
BackgroundSoluble receptor for advanced glycation end products (sRAGE) is a proposed emphysema and airflow obstruction biomarker; however, previous...
-
-
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality
BackgroundCOVID-19 pneumonia and subsequent respiratory failure is causing an immense strain on intensive care units globally. Early prediction of...
-
Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome
BackgroundAdvanced glycation end products (AGEs) are known to associate with the pathogenesis of several chronic diseases via interaction with their...
-
Correlation between circulating advanced glycation end products and thioredoxin-interacting protein levels and renal fat content in type 2 diabetes mellitus patients
BackgroundThis study sought to explore the clinical relevance of the associations of serum levels of advanced glycation end products (AGEs), soluble...
-
Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
BackgroundTo evaluate the association of serum advanced glycation end-products (AGEs) and its soluble receptor of AGE (sRAGE) levels with...
-
High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone
Blood levels of the soluble receptor for advanced glycation end-products (sRAGE) are acutely elevated during the host inflammatory response to...
-
Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study
PurposeAdvanced glycation end products (AGEs) are responsible for the complications in type 2 diabetes mellitus (T2DM) patients by acting via its...
-
Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea
BackgroundHypoxia can reduce the levels of soluble receptor for advanced glycation end-products (sRAGE), a new anti-inflammatory biomarker of COPD....
-
Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome
Atrial fibrillation (AF) is highly prevalent in hypertensive patients with metabolic syndrome and is related to inflammation and activation of the...
-
Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study
BackgroundAdvanced glycation end-products (AGEs) and their interaction with the receptor for advanced glycation end-products (RAGE) play a pivotal...
-
The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study
BackgroundChronic obstructive pulmonary disease (COPD) and asthma associate with high morbidity and mortality. High levels of advanced glycation end...
-
Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto’s thyroiditis
PurposeAdvanced glycation end products (AGEs) are increased in conditions of oxidative stress and promote inflammation by interacting with their...
